Heron Therapeutics Inc. buy Needham & Company LLC
Start price
15.11.23
/
50%
€0.77
Target price
15.11.24
€3.68
Performance (%)
69.93%
Price
07.12.23
€1.30
Summary
This prediction is currently active. The BUY prediction by Needham___Company_LL for Heron Therapeutics Inc. has seen massive gains of 69.93%. This prediction currently runs until 15.11.24. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Heron Therapeutics Inc. | 5.691% |
| iShares Core DAX® | 2.122% |
| iShares Nasdaq 100 | 1.636% |
| iShares Nikkei 225® | -0.215% |
| iShares S&P 500 | 1.321% |
Comments by Needham___Company_LL for this prediction
In the thread Heron Therapeutics Inc. diskutieren
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its price target lowered by analysts at Needham & Company LLC from $5.00 to $4.00. They now have a "buy" rating on the stock.
Ratings data for HRTX provided by MarketBeat
Stopped prediction by Needham___Company_LL for Heron Therapeutics Inc.
Heron Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.37
15.08.23
15.08.23
€4.58
15.08.24
15.08.24
-5.11%
07.12.23
07.12.23
Heron Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.31
25.07.23
25.07.23
€4.52
25.07.24
25.07.24
-0.76%
07.12.23
07.12.23
Heron Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.40
24.04.23
24.04.23
€6.35
24.04.24
24.04.24
-43.33%
07.12.23
07.12.23
Heron Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.77
24.03.23
24.03.23
€6.51
24.03.24
24.03.24
-26.57%
07.12.23
07.12.23
